United Therapeutics Corp (NAS:UTHR)
$ 360.87 -2.78 (-0.76%) Market Cap: 16.11 Bil Enterprise Value: 13.18 Bil PE Ratio: 15.85 PB Ratio: 2.64 GF Score: 86/100

Q1 2024 United Therapeutics Corp Earnings Call Transcript

May 01, 2024 / 01:00PM GMT
Release Date Price: $255.14 (+8.88%)
Operator

Good morning, and welcome to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast. My name is Danielle, and I will be your conference operator today. (Operator Instructions) Please note, this call is being recorded. (Operator Instructions).

I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Thank you, Danielle, and good morning. It's my pleasure to welcome you to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements will involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including forms 10-K and 10-Q, contain additional information on these risks and uncertainties, and we assume no obligation to update forward-looking statements.

Today's remarks may discuss the progress and results of clinical trials or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot